Arcus Biosciences (RCUS) News Today $11.50 0.00 (0.00%) Closing price 09/12/2025 03:59 PM EasternExtended Trading$11.40 -0.10 (-0.83%) As of 09/12/2025 05:25 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock RCUS Latest News All Sources Trusted Sources MarketBeat Barchart Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent September 2025 August 2025 July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 Time Period Arcus Biosciences, Inc. $RCUS Shares Acquired by Woodline Partners LPSeptember 12 at 6:41 AM | marketbeat.comArcus Biosciences (NYSE:RCUS) Stock Price Down 8% - Here's WhySeptember 10, 2025 | marketbeat.comArcus Biosciences, Inc. (RCUS) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference TranscriptSeptember 10, 2025 | seekingalpha.comJacobs Levy Equity Management Inc. Acquires 506,853 Shares of Arcus Biosciences, Inc. $RCUSSeptember 10, 2025 | marketbeat.comBrokerages Set Arcus Biosciences, Inc. (NYSE:RCUS) Target Price at $21.14September 9, 2025 | americanbankingnews.comArcus Biosciences Announces New Employment Inducement GrantsSeptember 8, 2025 | businesswire.comParkman Healthcare Partners LLC Has $9.54 Million Holdings in Arcus Biosciences, Inc. $RCUSSeptember 8, 2025 | marketbeat.comGranahan Investment Management LLC Purchases 133,497 Shares of Arcus Biosciences, Inc. $RCUSSeptember 8, 2025 | marketbeat.comArcus Biosciences, Inc. (NYSE:RCUS) Receives Consensus Rating of "Moderate Buy" from BrokeragesSeptember 8, 2025 | marketbeat.comTrexquant Investment LP Sells 85,182 Shares of Arcus Biosciences, Inc. $RCUSSeptember 7, 2025 | marketbeat.comAlexander Azoy Sells 1,579 Shares of Arcus Biosciences (NYSE:RCUS) StockSeptember 6, 2025 | insidertrades.comCutter Capital Management LP Purchases New Stake in Arcus Biosciences, Inc. $RCUSSeptember 6, 2025 | marketbeat.comArcus Biosciences, Inc. $RCUS Shares Sold by PDT Partners LLCSeptember 6, 2025 | marketbeat.comArcus Biosciences (NYSE:RCUS) Trading Up 8.5% - Should You Buy?September 5, 2025 | marketbeat.comRA Capital Management L.P. Takes Position in Arcus Biosciences, Inc. $RCUSSeptember 4, 2025 | marketbeat.comWalleye Capital LLC Takes $428,000 Position in Arcus Biosciences, Inc. $RCUSSeptember 4, 2025 | marketbeat.comThese 3 “Strong Buy” Value Stocks Have over 10% Upside, According to Analysts – 9/3/2025September 3, 2025 | msn.comArcus Biosciences, Inc. (RCUS) Presents At Citi's Biopharma Back To School Conference TranscriptSeptember 3, 2025 | seekingalpha.comRafferty Asset Management LLC Has $882,000 Position in Arcus Biosciences, Inc. $RCUSSeptember 3, 2025 | marketbeat.comNuveen LLC Takes Position in Arcus Biosciences, Inc. $RCUSSeptember 3, 2025 | marketbeat.comArcus Biosciences to Host Investor Event to Highlight its Late-Stage Casdatifan Program and Next Wave of Programs Focused on InflammationSeptember 2, 2025 | businesswire.comArcus Biosciences, Inc. $RCUS Shares Acquired by DAFNA Capital Management LLCSeptember 1, 2025 | marketbeat.comRussell Investments Group Ltd. Has $759,000 Stake in Arcus Biosciences, Inc. $RCUSSeptember 1, 2025 | marketbeat.comInvesco Ltd. Has $1.99 Million Stock Holdings in Arcus Biosciences, Inc. $RCUSSeptember 1, 2025 | marketbeat.comWellington Management Group LLP Acquires New Stake in Arcus Biosciences, Inc. $RCUSAugust 31, 2025 | marketbeat.comCharles Schwab Investment Management Inc. Grows Stock Position in Arcus Biosciences, Inc. $RCUSAugust 30, 2025 | marketbeat.comCampbell & CO Investment Adviser LLC Makes New $1.30 Million Investment in Arcus Biosciences, Inc. $RCUSAugust 29, 2025 | marketbeat.comSwiss National Bank Boosts Stake in Arcus Biosciences, Inc. $RCUSAugust 28, 2025 | marketbeat.comVanguard Group Inc. Has $52.50 Million Position in Arcus Biosciences, Inc. $RCUSAugust 28, 2025 | marketbeat.comArcus Biosciences, Inc. $RCUS Stock Holdings Lifted by Algert Global LLCAugust 24, 2025 | marketbeat.comArcus Biosciences, Inc. $RCUS Shares Purchased by Public Sector Pension Investment BoardAugust 24, 2025 | marketbeat.comArcus Biosciences to Participate in Three Upcoming Investor ConferencesAugust 22, 2025 | theglobeandmail.comGilead Sciences Inc. Raises Position in Arcus Biosciences, Inc. (NYSE:RCUS)August 19, 2025 | marketbeat.comJim Cramer on Arcus Biosciences: “Let This Be Your Speculation”August 16, 2025 | finance.yahoo.comCramer's Lightning Round: Uranium Energy is a buyAugust 14, 2025 | msn.comArcus Biosciences, Inc. (NYSE:RCUS) Receives Average Recommendation of "Moderate Buy" from BrokeragesAugust 12, 2025 | marketbeat.comCantor Fitzgerald Issues Positive Forecast for RCUS EarningsAugust 11, 2025 | marketbeat.comQ3 EPS Forecast for Arcus Biosciences Reduced by AnalystAugust 11, 2025 | marketbeat.comLeerink Partnrs Has Negative Estimate for RCUS Q3 EarningsAugust 11, 2025 | marketbeat.comWedbush Forecasts Lower Earnings for Arcus BiosciencesAugust 11, 2025 | marketbeat.comArcus Biosciences: A Risky Buy Ahead Of Pivotal, Catalyst-Rich 12 MonthsAugust 10, 2025 | seekingalpha.comArcus Biosciences (NYSE:RCUS) Stock Rating Upgraded by Wall Street ZenAugust 10, 2025 | marketbeat.comWedbush Decreases Earnings Estimates for Arcus BiosciencesAugust 9, 2025 | marketbeat.comArcus Biosciences (NYSE:RCUS) Price Target Lowered to $25.00 at Wells Fargo & CompanyAugust 8, 2025 | marketbeat.comArcus (RCUS) Q2 Revenue Jumps 310%August 6, 2025 | fool.comArcus Biosciences Reports Second-Quarter 2025 Financial Results and Provides a Pipeline UpdateAugust 6, 2025 | gurufocus.comArcus Biosciences Reports Second-Quarter 2025 Financial Results and Provides a Pipeline UpdateAugust 6, 2025 | businesswire.comArcus Biosciences’ Pancreatic Cancer Drug Quemliclustat Receives Orphan Drug Designation from FDAJuly 31, 2025 | msn.comArcus Biosciences (RCUS) Projected to Post Quarterly Earnings on WednesdayJuly 31, 2025 | marketbeat.comY Intercept Hong Kong Ltd Makes New Investment in Arcus Biosciences, Inc. (NYSE:RCUS)July 31, 2025 | marketbeat.com Get Arcus Biosciences News Delivered to You Automatically Sign up to receive the latest news and ratings for RCUS and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. RCUS Media Mentions By Week RCUS Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. RCUS News Sentiment▼1.100.93▲Average Medical News Sentiment RCUS News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. RCUS Articles This Week▼97▲RCUS Articles Average Week Get the Latest News and Ratings for RCUS and Related Stocks Enter your email address to receive the latest news and analysts' ratings for Arcus Biosciences and its competitors. Sign Up View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Related Companies and Tools Related Companies TG Therapeutics News Today Merus News Today CRISPR Therapeutics News Today PTC Therapeutics News Today Krystal Biotech News Today Vaxcyte News Today ACADIA Pharmaceuticals News Today Arcellx News Today ADMA Biologics News Today Arrowhead Pharmaceuticals News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NYSE:RCUS) was last updated on 9/14/2025 by MarketBeat.com Staff From Our PartnersNvidia Times 1,000,000Nvidia’s latest AI chip is a $25,000 powerhouse — with 80 billion transistors and the ability to perform 60 tr...Paradigm Press | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredApple’s falling behindApple just posted record-breaking results, yet its stock barely moved — because in today’s market, investors o...Porter & Company | Sponsored6-Figure Target for BTC by 2025The U.S. just announced it's putting GDP data directly onto Bitcoin and Ethereum blockchains. Could this spa...Crypto 101 Media | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredEveryone thought he was insane…SpaceX just struck a $17 billion deal with EchoStar for radio frequencies, and tech analyst Jeff Brown says it...Brownstone Research | SponsoredCrypto Income (almost instantly)How would you like to collect a small percentage of the $4 billion changing hands daily in the crypto market? ...Awesomely, LLC | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Arcus Biosciences, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Arcus Biosciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
